These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29668208)

  • 21. Does antidepressant step therapy fuel the law of unintended consequences?
    Greden JF
    Am J Psychiatry; 2010 Oct; 167(10):1148-51. PubMed ID: 20889657
    [No Abstract]   [Full Text] [Related]  

  • 22. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
    Cheng N; Banerjee T; Qian J; Hansen RA
    J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of cost-sharing on treatment augmentation in patients with depression.
    Gibson TB; Jing Y; Bagalman JE; Cao Z; Bates JA; Hebden T; Forbes RA; Doshi JA
    Am J Manag Care; 2012 Jan; 18(1):e15-22. PubMed ID: 22435786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder.
    Seetasith A; Greene M; Hartry A; Burudpakdee C
    J Med Econ; 2018 Sep; 21(9):888-901. PubMed ID: 29862860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychiatrists' decision making between branded and generic drugs.
    Hamann J; Mendel R; Kissling W; Leucht S
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):686-90. PubMed ID: 23021566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.
    Valuck RJ; Libby AM; Sills MR; Giese AA; Allen RR
    CNS Drugs; 2004; 18(15):1119-32. PubMed ID: 15581382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical expenditures associated with major depressive disorder among privately insured working-age adults with diagnosed diabetes in the United States, 2008.
    Shrestha SS; Zhang P; Li R; Thompson TJ; Chapman DP; Barker L
    Diabetes Res Clin Pract; 2013 Apr; 100(1):102-10. PubMed ID: 23490596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in generic sertraline for children: real or artefact from cost containing to clinical quality of generics use.
    Maurizio B; Silvia M; Antonio C
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1083-5. PubMed ID: 17089109
    [No Abstract]   [Full Text] [Related]  

  • 29. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicaid prescription limits: policy trends and comparative impact on utilization.
    Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
    BMC Health Serv Res; 2016 Jan; 16():15. PubMed ID: 26772962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brand loyalty, patients and limited generic medicines uptake.
    Costa-Font J; Rudisill C; Tan S
    Health Policy; 2014 Jun; 116(2-3):224-33. PubMed ID: 24573104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of antidepressant step therapy protocols on pharmaceutical and medical utilization and expenditures.
    Mark TL; Gibson TM; McGuigan K; Chu BC
    Am J Psychiatry; 2010 Oct; 167(10):1202-9. PubMed ID: 20713497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physician prescribing patterns of innovative antidepressants in the United States: the case of MDD patients 1993-2007.
    Lin HC; Erickson SR; Balkrishnan R
    Int J Psychiatry Med; 2011; 42(4):353-68. PubMed ID: 22530398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorder.
    Sussman M; Yu J; Kamat SA; Hartry A; Legacy S; Duffy R; Aigbogun MS
    J Affect Disord; 2017 Jan; 207():54-62. PubMed ID: 27693466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.
    Gupta S; Gersing KR; Erkanli A; Burt T
    Psychiatr Q; 2016 Jun; 87(2):329-42. PubMed ID: 26303613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.
    Kwong WJ; Kamat S; Fang C
    Ann Pharmacother; 2012 Dec; 46(12):1609-16. PubMed ID: 23150608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.
    Wang J; Liu X; Mullins CD
    Curr Med Res Opin; 2011 Jul; 27(7):1303-13. PubMed ID: 21561393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myopic and Forward Looking Behavior in Branded Oral Anti-Diabetic Medication Consumption: An Example from Medicare Part D.
    Sacks NC; Burgess JF; Cabral HJ; Pizer SD
    Health Econ; 2017 Jun; 26(6):753-764. PubMed ID: 27150938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generic utilization and cost-sharing for prescription drugs.
    Gibson TB; McLaughlin CG; Smith DG
    Adv Health Econ Health Serv Res; 2010; 22():195-219. PubMed ID: 20575234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription analysis and cost of antidepressant drugs in major depressive disorder outpatients at the tertiary care hospital of Pakistan: a prospective approach.
    Kamran S; Khan Z; Saqlain M; Nazar Z; Khan M; Ali Z; Rashid H; Shah KU; Karatas Y; Rahman NU
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jul; 22(5):845-851. PubMed ID: 34927501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.